The World Health Organization (WHO) has approved a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use.
The decision will allow CoronaVac to be used in WHO’s vaccine-sharing program, COVAX, which seeks to provide equitable global access to immunizations.
It is the second Chinese vaccine given WHO approval after Sinopharm was approved in early May.
WHO Director-General Tedros Adhanom Ghebreyesus said at a news briefing Tuesday that CoronaVac was “found to be safe, effective, and quality-assured following two doses of the inactivated vaccine.”
WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has recommended the vaccine for people over 18. Two doses should be spaced between two and four weeks.
Unlike some other vaccines, CoronaVac doesn’t need to be kept at super-cold temperatures.
more recommended stories
My Country, Somaliland, RecognizedOur first embassy will be in.
The Arithmetic of Erasure: Deconstructing Mogadishu’s NarrativeBy Abdiwahab Sancawl When the UN.
Somaliland Recognition: A Litmus Test for Israel’s Post Gaza Global influenceIsrael’s recognition of Somaliland, a long.
-
Awdal’s Strategic Role in Somaliland’s Statehood and National Stability
The people of Awdal, particularly those.